Uspeshnoe lechenie prolaktinomy kabergolinom: neyroendokrinnye i metabolicheskie aspekty

Cover Page

Abstract



  • Марова Е.И., Вакс В.В., Дзеранова Л.К. Гиперпролактинемия у женщин и мужчин: Пособие для врачей. Pharmacia and Upjohn.
  • Мокрышева Н.Г. Состояние жирового обмена и костного метаболизма у пациенток репродуктивного возраста с гиперпролактинемией опухолевого генеза: Автореф. дис. … канд. мед. наук. М.; 2003: 10-12.
  • Овсянникова Т.В. Патогенез, клиника, диагностика и отдаленные результаты лечения бесплодия при гиперпролактинемии у женщин: Дис. ... д-р мед. наук. М.; 1990: 316.
  • Осипова А. А., Сметник В.П. Избыточная масса тела и абдоминальный тип ожирения у пациенток с опухолевой и неопухолевой формами гиперпролактинемии; влияние терапии парлоделом, норпролаком и достинексом. Проблемы репродукции 2002; 12-17.
  • Allison, D.B., Casey, D.E. (2001). Antipsychotic-induced weight gain: a review of the literature J Clin Psychiatry 62, 22-31.
  • Barash I., Cheung C., Weigle D. et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996; 137: 3144-3147.
  • Bina, K.G., Cincotta, A.H. (2000). Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice Neuroendocrinology 71, 68-78.
  • Breckwoldt M., Crosignani P. A new treatment Option for Hyperprolactinemic Disorders. XI Ann. Meeting of the European Society of Human Reproduction and Embriology 1995.
  • Campfield A., Smith F., Burn P. The OB protein (Leptin) pathway - A link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28: 619-632.
  • Goffin V. et al. From the molecular biology of prolactin and its receptor to the lessons learned from knocout mice models. Genetic Analysis. Biomolecular Engineering 1999; 15: 189-201.
  • Greenman Y., Tordjman K., Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol Oxford 1998; 48(5): 547-553.
  • Doknic M., Pecis S., Zarcovic M. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. European Journal of Endocrinology 2002; 147: 77-84.
  • Korner Judith, Janet Lo, Pamela U. Freda and Sharon L. Wardlaw. Treatment with Cabergoline Is Associated with Weight Loss in Patients with Hyperprolactinemia. Clin Endocrinol 2002; July 11.
  • Lacruz, A., Baptista, T., de Mendoza, S., Mendoza-Guillen, J.M., Hernandez, L. (2000). Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment Mol Psychiatry 5, 70-6.
  • Meier A. Temporal synergism of corticosterone and prolactin controlling seasonal conditions in the white throated sparrow, Zonotrichia albicolis. The history of clinical endocrinology. V. Medvei. London: Parthenon Publishing Group 1993.
  • Szczypka, M.S., Rainey, M.A., Kim, D.S., et al. (1999). Feeding behavior in dopamine-deficient mice Proc Natl Acad Sci USA 96, 12138-43.
  • Szczypka, M.S., Rainey, M.A., Palmiter, R.D. (2000) Dopamine is required for hyperphagia in Lep ob/ob mice Nat Genet 25, 102-4.

Views

Abstract - 396

PDF (Russian) - 272


Copyright (c) 2007 Dzeranova L.K., Giniyatullina E.N., Dobracheva A.D., Pigarova E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.